Atlas Trials

BiRd vs. Rd as Initial Therapy in Multiple Myeloma

Clinical trial NCT02516696 · TERMINATED

Trial details

NCT number
NCT02516696
Sponsor
Weill Medical College of Cornell University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2016-02-01
Primary completion
2022-06-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.